831 related articles for article (PubMed ID: 21419659)
1. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.
Sato M; Waddell TK; Wagnetz U; Roberts HC; Hwang DM; Haroon A; Wagnetz D; Chaparro C; Singer LG; Hutcheon MA; Keshavjee S
J Heart Lung Transplant; 2011 Jul; 30(7):735-42. PubMed ID: 21419659
[TBL] [Abstract][Full Text] [Related]
2. Revisiting the pathologic finding of diffuse alveolar damage after lung transplantation.
Sato M; Hwang DM; Ohmori-Matsuda K; Chaparro C; Waddell TK; Singer LG; Hutcheon MA; Keshavjee S
J Heart Lung Transplant; 2012 Apr; 31(4):354-63. PubMed ID: 22330935
[TBL] [Abstract][Full Text] [Related]
3. Comparison of bronchiolitis obliterans syndrome to other forms of chronic lung allograft dysfunction after lung transplantation.
Woodrow JP; Shlobin OA; Barnett SD; Burton N; Nathan SD
J Heart Lung Transplant; 2010 Oct; 29(10):1159-64. PubMed ID: 20580267
[TBL] [Abstract][Full Text] [Related]
4. Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder?
Burton CM; Iversen M; Mortensen J; Carlsen J; Andersen CB; Milman N; Scheike T
J Heart Lung Transplant; 2007 Nov; 26(11):1127-34. PubMed ID: 18022078
[TBL] [Abstract][Full Text] [Related]
5. Time-dependent changes in the risk of death in pure bronchiolitis obliterans syndrome (BOS).
Sato M; Ohmori-Matsuda K; Saito T; Matsuda Y; Hwang DM; Waddell TK; Singer LG; Keshavjee S
J Heart Lung Transplant; 2013 May; 32(5):484-91. PubMed ID: 23433813
[TBL] [Abstract][Full Text] [Related]
6. Validation of a post-transplant chronic lung allograft dysfunction classification system.
Van Herck A; Verleden SE; Sacreas A; Heigl T; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck D; Verleden GM; Vos R
J Heart Lung Transplant; 2019 Feb; 38(2):166-173. PubMed ID: 30391199
[TBL] [Abstract][Full Text] [Related]
7. Neutrophilic reversible allograft dysfunction (NRAD) and restrictive allograft syndrome (RAS).
Verleden SE; Vandermeulen E; Ruttens D; Vos R; Vaneylen A; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM; Verleden GM
Semin Respir Crit Care Med; 2013 Jun; 34(3):352-60. PubMed ID: 23821509
[TBL] [Abstract][Full Text] [Related]
8. Low-dose computed tomography volumetry for subtyping chronic lung allograft dysfunction.
Saito T; Horie M; Sato M; Nakajima D; Shoushtarizadeh H; Binnie M; Azad S; Hwang DM; Machuca TN; Waddell TK; Singer LG; Cypel M; Liu M; Paul NS; Keshavjee S
J Heart Lung Transplant; 2016 Jan; 35(1):59-66. PubMed ID: 26342441
[TBL] [Abstract][Full Text] [Related]
9. Survival determinants in lung transplant patients with chronic allograft dysfunction.
Verleden GM; Vos R; Verleden SE; De Wever W; De Vleeschauwer SI; Willems-Widyastuti A; Scheers H; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM
Transplantation; 2011 Sep; 92(6):703-8. PubMed ID: 21836537
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunction.
Todd JL; Neely ML; Finlen Copeland CA; Frankel CW; Reynolds JM; Palmer SM
J Heart Lung Transplant; 2019 Feb; 38(2):184-193. PubMed ID: 30466803
[TBL] [Abstract][Full Text] [Related]
11. Bronchiolitis obliterans syndrome and restrictive allograft syndrome: do risk factors differ?
Verleden SE; Ruttens D; Vandermeulen E; Vaneylen A; Dupont LJ; Van Raemdonck DE; Verleden GM; Vanaudenaerde BM; Vos R
Transplantation; 2013 May; 95(9):1167-72. PubMed ID: 23425818
[TBL] [Abstract][Full Text] [Related]
12. Risk assessment of chronic lung allograft dysfunction phenotypes: Validation and proposed refinement of the 2019 International Society for Heart and Lung Transplantation classification system.
Levy L; Huszti E; Renaud-Picard B; Berra G; Kawashima M; Takahagi A; Fuchs E; Ghany R; Moshkelgosha S; Keshavjee S; Singer LG; Tikkanen J; Martinu T
J Heart Lung Transplant; 2020 Aug; 39(8):761-770. PubMed ID: 32418864
[TBL] [Abstract][Full Text] [Related]
13. Quantitative chest CT for subtyping chronic lung allograft dysfunction and its association with survival.
Horie M; Salazar P; Saito T; Binnie M; Brock K; Yasufuku K; Azad S; Keshavjee S; Martinu T; Paul N
Clin Transplant; 2018 May; 32(5):e13233. PubMed ID: 29637624
[TBL] [Abstract][Full Text] [Related]
14. Acute cellular rejection is a risk factor for bronchiolitis obliterans syndrome independent of post-transplant baseline FEV1.
Burton CM; Iversen M; Carlsen J; Mortensen J; Andersen CB; Steinbrüchel D; Scheike T
J Heart Lung Transplant; 2009 Sep; 28(9):888-93. PubMed ID: 19716040
[TBL] [Abstract][Full Text] [Related]
15. Lung volumes predict survival in patients with chronic lung allograft dysfunction.
Kneidinger N; Milger K; Janitza S; Ceelen F; Leuschner G; Dinkel J; Königshoff M; Weig T; Schramm R; Winter H; Behr J; Neurohr C
Eur Respir J; 2017 Apr; 49(4):. PubMed ID: 28404648
[TBL] [Abstract][Full Text] [Related]
16. Impact of oropharyngeal dysphagia on long-term outcomes of lung transplantation.
Atkins BZ; Petersen RP; Daneshmand MA; Turek JW; Lin SS; Davis RD
Ann Thorac Surg; 2010 Nov; 90(5):1622-8. PubMed ID: 20971276
[TBL] [Abstract][Full Text] [Related]
17. Use of CT-SCAN score and volume measures to early identify restrictive allograft syndrome in single lung transplant recipients.
Philippot Q; Debray MP; Bun R; Frija-Masson J; Bunel V; Morer L; Roux A; Picard C; Jebrak G; Dauriat G; Castier Y; Cazes A; Mal H; Taupin JL; Couffignal C; Brugière O
J Heart Lung Transplant; 2020 Feb; 39(2):125-133. PubMed ID: 31836403
[TBL] [Abstract][Full Text] [Related]
18. Primary graft dysfunction and long-term pulmonary function after lung transplantation.
Whitson BA; Prekker ME; Herrington CS; Whelan TP; Radosevich DM; Hertz MI; Dahlberg PS
J Heart Lung Transplant; 2007 Oct; 26(10):1004-11. PubMed ID: 17919620
[TBL] [Abstract][Full Text] [Related]
19. Single-lung transplantation: does side matter?
Tsagkaropoulos S; Belmans A; Verleden GM; Coosemans W; Decaluwe H; De Leyn P; Nafteux P; Van Raemdonck D
Eur J Cardiothorac Surg; 2011 Aug; 40(2):e83-92. PubMed ID: 21497108
[TBL] [Abstract][Full Text] [Related]
20. Impact of forced vital capacity loss on survival after the onset of chronic lung allograft dysfunction.
Todd JL; Jain R; Pavlisko EN; Finlen Copeland CA; Reynolds JM; Snyder LD; Palmer SM
Am J Respir Crit Care Med; 2014 Jan; 189(2):159-66. PubMed ID: 24325429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]